DOW JONES23,119.60+465.74 2.06%
S&P 5002,710.55+51.14 1.92%
NASDAQ8,040.26+153.00 1.94%

Cantor Fitzgerald Initiates Coverage On ZIOPHARM Oncology with Overweight Rating, Announces $6 Price Target

Cantor Fitzgerald initiates coverage on ZIOPHARM Oncology (NASDAQ:ZIOP) with a Overweight rating and a $6 price target.

Benzinga · 03/04/2020 10:10

Cantor Fitzgerald initiates coverage on ZIOPHARM Oncology (NASDAQ:ZIOP) with a Overweight rating and a $6 price target.